US National Organic Standards Board needs to define "nanotechnology"
Canada has banned nanotechnology in organic food production. An amendment was added to Canada's national organic rules banning nanotechnology as a "Prohibited Substance or Method." The section lists substances or techniques that are prohibited in organic food production, including genetic engineering, synthetic pesticides, irradiation, and cloned animals, among others.
Nanotechnology involves the creation and manipulation of materials at the scale of atoms and molecules. Scientists are applying nanotechnology to many industries, including food production. Critics say that too little is known about the impact of nanoparticles on human health and the environment.
Health & Wellness
After many attempts to find a place to meet, we settled on having organic herbal tea at a local coffee shop. She greeted me in her new wardrobe. No, she's isn't an Angeleno fashionista. Rather, Monsanto owns most cotton seeds so she had to purchase clothes and shoes made from other sources. April is plain and soft-spoken - I wouldn't pick her to stand with a bull-horn outside of a McDonald's protest. Despite her demeanor, her month without Monsanto was her own small but very impactful way of positively affecting our food system.
© NaturalNews
The numbers have undoubtedly risen in the four years since; tattoos are now well-entrenched in the mainstream.
Even the media regularly glorifies tattoo culture, as evidenced by reality TV shows like The Learning Channel's Miami Ink and LA Ink, and Inked on A&E, as well as frequent magazine sightings of tattoo-sporting celebrities like Paris Hilton, David Beckham, and Angelina Jolie, and print ads featuring tattooed models and athletes, like Calvin Klein Underwear's Fredrik Ljungberg (who, by the way, had a severe allergic reaction to his tattoos and had to have a lymph gland removed).[2]
"Type 1 is rare and strikes out of the blue, due in part to a genetic risk, set off by perhaps a virus or some other kind of stress. To treat it, you take insulin, test your blood sugars, and carefully watch what you eat...Type 2 is far more widespread, and spreading fast along with America's waistline. It's caused by eating too much and exercising too little..."
Here in Ecuador, I regularly drink jugo de caña, for example (fresh, raw sugar cane juice), but I would never think of eating refined white sugar. I don't use refined white table salt, either. Instead, I use Himalayan Pink Crystal Salt because it contains the full spectrum of 84 minerals and trace elements just like Mother Earth intended. It is an unrefined, unprocessed "raw" salt that's hand-mined from abundant salt caves that were formed 250 million years ago as ocean salt settled in certain geologic pockets around the earth.
Most of the western world thinks of salt as sodium chloride - a highly refined, processed white substance that's devoid of nutrients. Salt is so devoid of nutrients, in fact, that in the early 20th century, doctors noticed that people who ate white table salt started to suffer chronic degenerative diseases such as goiter. This was caused by the lack of iodine in the salt.
© Getty Images
"Sleep duration has shortened considerably in western societies in the past decade and simultaneously, there has been an increase in the prevalence of insulin resistance and type 2 diabetes," said Esther Donga, MD of the Leiden University Medical Center in The Netherlands and lead author of the study. "The co-occurring rises in shortened sleep and diabetes prevalence may not be a coincidence. Our findings show a short night of sleep has more profound effects on metabolic regulation than previously appreciated."
Previous studies have found that reductions in sleep duration over multiple nights result in impaired glucose tolerance, but this is the first study to examine the effects of only a single night of partial sleep restriction on insulin sensitivity.
© Getty Images
"For many years, pediatricians and educators thought that as long as children have one normal hearing ear, their speech and language would develop normally," says lead author Judith E. C. Lieu, MD, a Washington University ear, nose and throat specialist at St. Louis Children's Hospital.
"But then a few studies began suggesting these children might have problems in school. Now our study has shown that on average, children with hearing loss in one ear have poorer oral language scores than children with hearing in both ears," Lieu says.
In May of 2000, shortly before I stepped down as editor-in-chief of the New England Journal of Medicine, I wrote an editorial entitled, "Is Academic Medicine for Sale?" It was prompted by a clinical trial of an antidepressant called Serzone that was published in the same issue of the Journal.
The authors of that paper had so many financial ties to drug companies, including the maker of Serzone, that a full-disclosure statement would have been about as long as the article itself, so it could appear only on our Web site. The lead author, who was chairman of the department of psychiatry at Brown University (presumably a full-time job), was paid more than half a million dollars in drug-company consulting fees in just one year. Although that particular paper was the immediate reason for the editorial, I wouldn't have bothered to write it if it weren't for the fact that the situation, while extreme, was hardly unique.
Among the many letters I received in response, two were especially pointed. One asked rhetorically, "Is academic medicine for sale? These days, everything is for sale." The second went further: "Is academic medicine for sale? No. The current owner is very happy with it." The author didn't feel he had to say who the current owner was.
The authors of that paper had so many financial ties to drug companies, including the maker of Serzone, that a full-disclosure statement would have been about as long as the article itself, so it could appear only on our Web site. The lead author, who was chairman of the department of psychiatry at Brown University (presumably a full-time job), was paid more than half a million dollars in drug-company consulting fees in just one year. Although that particular paper was the immediate reason for the editorial, I wouldn't have bothered to write it if it weren't for the fact that the situation, while extreme, was hardly unique.
Among the many letters I received in response, two were especially pointed. One asked rhetorically, "Is academic medicine for sale? These days, everything is for sale." The second went further: "Is academic medicine for sale? No. The current owner is very happy with it." The author didn't feel he had to say who the current owner was.
© NaturalNews
Scientists at the Ponce School of Medicine in Puerto Rico investigated 268 women with malignant breast tumors and 457 healthy controls to look for possible causative factors for breast cancer. The results, which were recently presented by Jaime Matta, Ph.D., at the American Association for Cancer Research's 101st Annual Meeting held in Washington, D.C., showed vitamin supplements reduced the risk of breast cancer by about 30%.
"It is not an immediate effect. You don't take a vitamin today and your breast cancer risk is reduced tomorrow. However, we did see a long-term effect in terms of breast cancer reduction," Dr. Matta, who headed the study, said in a statement to the press. "We're not talking about mega doses of these vitamins and calcium supplements, so this is definitely one way to reduce risk."
© Kirkland
Doctors have long recommended that people who have survived heart attacks or strokes take an aspirin a day in order to reduce their risk of dying from another cardiovascular event. Between 2005 and 2006, however, many health professionals began to recommend the practice in people who had never suffered a cardiovascular event, but who were considered "at risk" to do so - such as those over the age of 50, those with Type 2 diabetes or those with high blood pressure.
"Current evidence for primary prevention suggests the benefits and harms of aspirin in this setting may be more finely balanced than previously thought," said DTB editor Ike Ikeanacho, "even in individuals estimated to be at high risk of experiencing cardiovascular events, including those with diabetes or elevated blood pressure."
Comment: For more information about 'nanotechnology' read the following articles carried on SOTT:
More Research Urged on Nanoparticle Risk
Australia - Regulate nanotechnology industry
Nanotechnology - the new threat to food
Food Industry 'Too Secretive' Over Nanotechnology
Alert over the march of the 'grey goo' in nanotechnology Frankenfoods
Scientists Scared as Nanotechnology and Nanoparticles Become Common in Consumer Products